时间 : 2016-05-25 09:19:13 来源:
1.2011年10月22日-25日,美国眼科学年会在美国佛罗里达州的奥多兰举行,图为奥多治会议中心。
1.2011年10月22日-25日,美国眼科学年会在美国佛罗里达州的奥多兰举行,图为奥多治会议中心。
(1.TheOrangeCountyConventionCenterinOrlando,Florida,playedhosttotheAmericanAcademyofOphthalmology(AAO)2011AnnualMeeting,heldOctober22to25,2011.)
${FDPageBreak}
2.今年会议的亮点是:
(1)飞秒激光辅助白内障手术被视为“重大进展”
(2)MRSA眼部感染呈上升趋势,但治疗滞后
(3)青光眼患者用药依从性差异很大
(4)眼保健医生比家庭医生有更多筋骨劳伤的苦恼
(5)白内障手术有助于阿尔茨海默氏症患者
(6)iPad有助于提高视力不佳患者的阅读能力
(2.Amongthisyearshighlights:
(1)Femtosecondlaser-assistedcataractsurgeryisseenasa“majoradvance”
(2)MRSAeyeinfectionsareontherise,buttreatmentislagging
(3)Medicationcomplianceinpatientswithglaucomavarieswidely
(4)Eye-carephysicianshavemoremusculoskeletalwoesthanfamilyphysicians
(5)CataractsurgeryhelpspatientswithAlzheimersdisease
(6)TheiPadimprovesthereadingabilityofpatientswithlowvision)
${FDPageBreak}
3.飞秒激光助白内障手术一臂之力
(3.FemtosecondLaser-AssistedCataractSurgeryaMajorAdvance
Astudyprovidesstrongevidenceoftheincreasedsafetyandeffectivenessoflaser-mediatedemulsificationofcataractscomparedwithphacoemulsification.Theapproachusesfemtosecondlasertechnology,whichdeliversnear-infraredlighttocreateprecisesubsurfacecutsatdepthsthataregreaterthanthosepossibleusingconventionalapproaches.StephenSlade,MD,fromSlade&BakerVisionCenterinHouston,Texas,whowasnotinvolvedinthestudy,describedthistechniqueas“thesinglemostsignificantadvancementincataractsurgeryinthelast40years.”)
${FDPageBreak}
(4.NovelEyeInsertImprovesDiabeticMacularEdema
Anintravitrealinsertthatreleasesasustainedandcontrolledamountofthecorticosteroidfluocinoloneacetonideimprovedvisualacuityforaslongas3yearsinastudyofpatientswithdiabeticmacularedema.Thisresult“isparticularlyexciting,asitdemonstratesthatasingleinsertcanproviderapidandsustainedimprovementinvisualacuityforupto36months,”saidDavidBrown,MD,fromRetinalConsultantsofHouston,MethodistHospital,Texas,duringhispresentation.)
${FDPageBreak}
5.视网膜中央静脉阻塞1年新药物可维持视力
(5.NewDrugMaintainsVisualAcuityinCentralRetinalVeinOcclusionat1Year
PatientswithmacularedemacausedbycentralretinalveinocclusionwhoreceivedinjectionsofVEGFTrap-Eye(RegeneronPharmaceuticals)onanas-neededbasisafterreceivingthedrugonceamonthfor6monthsmaintainedtheirinitiallyimprovedvisualacuity,accordingto1-yearresultsoftheCOPERNICUStrial.“Thisisgoodinformation.VEGFTrap-Eyeworksandappearstohavesomedurabilityofeffectwhengivenonanas-neededbasis,”saidstudypresenterJuliaHaller,MD,ophthalmologist-in-chiefattheWillsEyeInstituteandprofessorandchairoftheDepartmentofOphthalmologyatThomasJeffersonUniversityinPhiladelphia,Pennsylvania.)
(责任编辑:jbwq)
Copyright© 2000-2024 www.9939.net All Rights Reserved 版权所有 皖ICP备18005611号-6
特别声明:本站信息仅供参考 不能作为诊断及医疗的依据 本站如有转载或引用文章涉及版权问题请速与我们联系
Copyright© 2000-2024 www.9939.net All Rights Reserved 版权所有 皖ICP备18005611号-6
特别声明:本站信息仅供参考 不能作为诊断及医疗的依据 本站如有转载或引用文章涉及版权问题请速与我们联系